These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22168384)

  • 1. Protein kinase A antagonist inhibits β-catenin nuclear translocation, c-Myc and COX-2 expression and tumor promotion in Apc(Min/+) mice.
    Brudvik KW; Paulsen JE; Aandahl EM; Roald B; Taskén K
    Mol Cancer; 2011 Dec; 10():149. PubMed ID: 22168384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C delta negatively modulates canonical Wnt pathway and cell proliferation in colon tumor cell lines.
    Hernández-Maqueda JG; Luna-Ulloa LB; Santoyo-Ramos P; Castañeda-Patlán MC; Robles-Flores M
    PLoS One; 2013; 8(3):e58540. PubMed ID: 23520519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.
    Larriba MJ; Ordóñez-Morán P; Chicote I; Martín-Fernández G; Puig I; Muñoz A; Pálmer HG
    PLoS One; 2011; 6(8):e23524. PubMed ID: 21858154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
    Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
    Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression.
    Zeineldin M; Cunningham J; McGuinness W; Alltizer P; Cowley B; Blanchat B; Xu W; Pinson D; Neufeld KL
    Oncogene; 2012 May; 31(19):2423-37. PubMed ID: 21996741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Pygo2 for Wnt/ß-catenin signaling activity during intestinal tumor initiation and progression.
    Talla SB; Brembeck FH
    Oncotarget; 2016 Dec; 7(49):80612-80632. PubMed ID: 27811361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for the tissue specificity of β-catenin oncogenesis.
    Sharma A; Sen JM
    Oncogene; 2013 Apr; 32(15):1901-9. PubMed ID: 22689057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-grade slightly elevated and polypoid colorectal adenomas display differential β-catenin-TCF/LEF activity, c-Myc, and cyclin D1 expression.
    Yang TW; Gao YH; Ma SY; Wu Q; Li ZF
    World J Gastroenterol; 2017 May; 23(17):3066-3076. PubMed ID: 28533663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear AXIN2 represses MYC gene expression.
    Rennoll SA; Konsavage WM; Yochum GS
    Biochem Biophys Res Commun; 2014 Jan; 443(1):217-22. PubMed ID: 24299953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear adenomatous polyposis coli suppresses colitis-associated tumorigenesis in mice.
    Zeineldin M; Miller MA; Sullivan R; Neufeld KL
    Carcinogenesis; 2014 Aug; 35(8):1881-90. PubMed ID: 24894865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical evaluation of adenomatous polyposis coli, beta-catenin, c-Myc, cyclin D1, p53, and retinoblastoma protein expression in syndromic and sporadic fundic gland polyps.
    Hassan A; Yerian LM; Kuan SF; Xiao SY; Hart J; Wang HL
    Hum Pathol; 2004 Mar; 35(3):328-34. PubMed ID: 15017589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
    Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
    Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HT-29 human colon cancer cell proliferation is regulated by cytosolic phospholipase A(2)α dependent PGE(2)via both PKA and PKB pathways.
    Kisslov L; Hadad N; Rosengraten M; Levy R
    Biochim Biophys Acta; 2012 Sep; 1821(9):1224-34. PubMed ID: 22728329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A two-step model for colon adenoma initiation and progression caused by APC loss.
    Phelps RA; Chidester S; Dehghanizadeh S; Phelps J; Sandoval IT; Rai K; Broadbent T; Sarkar S; Burt RW; Jones DA
    Cell; 2009 May; 137(4):623-34. PubMed ID: 19450512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation of Epac1/Rap1/Akt and PKA in prostaglandin E(2) -induced proliferation of human umbilical cord blood derived mesenchymal stem cells: involvement of c-Myc and VEGF expression.
    Jang MW; Yun SP; Park JH; Ryu JM; Lee JH; Han HJ
    J Cell Physiol; 2012 Dec; 227(12):3756-67. PubMed ID: 22378492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway.
    Wei LH; Lin JM; Chu JF; Chen HW; Li QY; Peng J
    Chin J Integr Med; 2017 Nov; 23(11):858-863. PubMed ID: 29080197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A20 restricts wnt signaling in intestinal epithelial cells and suppresses colon carcinogenesis.
    Shao L; Oshima S; Duong B; Advincula R; Barrera J; Malynn BA; Ma A
    PLoS One; 2013; 8(5):e62223. PubMed ID: 23671587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
    Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
    J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Casein kinase 2- and protein kinase A-regulated adenomatous polyposis coli and beta-catenin cellular localization is dependent on p38 MAPK.
    Hildesheim J; Salvador JM; Hollander MC; Fornace AJ
    J Biol Chem; 2005 Apr; 280(17):17221-6. PubMed ID: 15649893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Endogenous Adenomatous Polyposis Coli Interaction Partners and β-Catenin-Independent Targets by Proteomics.
    Popow O; Paulo JA; Tatham MH; Volk MS; Rojas-Fernandez A; Loyer N; Newton IP; Januschke J; Haigis KM; Näthke I
    Mol Cancer Res; 2019 Sep; 17(9):1828-1841. PubMed ID: 31160382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.